These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29941300)

  • 1. Statistical motion modelling for robust evaluation of clinically delivered accumulated dose distributions after curative radiotherapy of locally advanced prostate cancer.
    Hysing LB; Ekanger C; Zolnay Á; Helle SI; Rasi M; Heijmen BJM; Sikora M; Söhn M; Muren LP; Thörnqvist S
    Radiother Oncol; 2018 Aug; 128(2):327-335. PubMed ID: 29941300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
    Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.
    Stasi M; Munoz F; Fiorino C; Pasquino M; Baiotto B; Marini P; Malinverni G; Valdagni R; Gabriele P
    Radiother Oncol; 2006 Sep; 80(3):363-70. PubMed ID: 16959344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of various online IGRT strategies: The benefits of online treatment plan re-optimization.
    Schulze D; Liang J; Yan D; Zhang T
    Radiother Oncol; 2009 Mar; 90(3):367-76. PubMed ID: 18976828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the clinical impact of the differences between planned and delivered dose in prostate cancer radiotherapy based on CT-on-rails IGRT and patient-reported outcome scores.
    Hammers J; Lindsay D; Narayanasamy G; Sud S; Tan X; Dooley J; Marks LB; Chen RC; Das SK; Mavroidis P
    J Appl Clin Med Phys; 2023 Jan; 24(1):e13780. PubMed ID: 36087039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.
    Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):444-453. PubMed ID: 26907917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMLC tracking and gating can improve dose coverage for prostate VMAT.
    Colvill E; Poulsen PR; Booth JT; O'Brien RT; Ng JA; Keall PJ
    Med Phys; 2014 Sep; 41(9):091705. PubMed ID: 25186380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol.
    Mott JH; Livsey JE; Logue JP
    Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
    Liu F; Ahunbay E; Lawton C; Li XA
    Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
    Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
    Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
    Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of robustness of IMPT and IMRT for prostate cancer against organ movement.
    Soukup M; Söhn M; Yan D; Liang J; Alber M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):941-9. PubMed ID: 19801105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an application for intensity-based deformable image registration and dose accumulation in radiotherapy.
    Thor M; Andersen ES; Petersen JB; Sørensen TS; Noe KØ; Tanderup K; Bentzen L; Elstrøm UV; Høyer M; Muren LP
    Acta Oncol; 2014 Oct; 53(10):1329-36. PubMed ID: 24957554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
    Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M
    Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer.
    Liu YM; Shiau CY; Lee ML; Huang PI; Hsieh CM; Chen PH; Lin YH; Wang LW; Yen SH
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1113-23. PubMed ID: 17197126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.